History and background
Glutathione was first isolated in 1888 by J. de Rey-Pailhade from yeast and animal tissues, and its exact structure as the tripeptide γ-L-glutamyl-L-cysteinylglycine was established by Frederick Hopkins in the 1920s. The classic work of Alton Meister through the 1970s and 1980s transformed glutathione from a descriptive "reducing substance" into a central hub of cellular sulfur and nitrogen metabolism, elucidating the γ-glutamyl cycle, the enzymes of its synthesis and degradation, and the regulation of the thiol pool [1]. Since then GSH has been recognized as the most abundant intracellular non-protein thiol: its cytosolic concentration in most mammalian cells reaches 1–10 mM, making it the dominant low-molecular-weight redox buffer [5].
Structure and physicochemistry
Glutathione (C₁₀H₁₇N₃O₆S, molar mass 307.32 g·mol⁻¹, CAS (Chemical Abstracts Service number) 70-18-8) is a tripeptide in which glutamate is joined to cysteine through an unusual γ-carboxyl (rather than α-) peptide bond, while glycine attaches to cysteine via a standard α-bond. It is precisely this γ-glutamyl linkage that renders the molecule resistant to cleavage by ordinary intracellular peptidases; it is hydrolyzed only by γ-glutamyltransferase (GGT) at the outer membrane surface [1]. The reactive center is the cysteine sulfhydryl (-SH) group with a pKa near 8.7–9.2; the thiolate anion (-S⁻) accounts for its nucleophilicity and reducing power.
On oxidation the reduced form (GSH) yields the disulfide (GSSG), in which two molecules are joined by an -S-S- bridge. The GSH/GSSG ratio (typically >100:1 in healthy cells) is a quantitative index of intracellular redox potential; the standard potential of the 2GSH/GSSG couple is about −240 mV [6]. The compound is a white crystalline powder, freely water-soluble and poorly soluble in alcohol; aqueous solutions are more stable at mildly acidic pH and are rapidly oxidized by atmospheric oxygen at neutral and alkaline pH, especially in the presence of transition-metal ions.
Biosynthesis and the γ-glutamyl cycle
GSH is synthesized in the cytosol of virtually all cells in two ATP-dependent steps. The first, rate-limiting step is catalyzed by glutamate-cysteine ligase (GCL, formerly γ-glutamylcysteine synthetase), forming γ-glutamylcysteine; the enzyme is a heterodimer of a catalytic (GCLC) and a modulatory (GCLM) subunit, and GCLM lowers the Km for glutamate and relieves feedback inhibition of GCL by the end-product GSH [2][4]. The second step, glutathione synthetase, adds glycine to complete the tripeptide. Cysteine availability is usually the substrate-limiting factor for synthesis [3].
Expression of GCLC/GCLM is induced through the transcription factor Nrf2, which binds antioxidant response elements (ARE) in the promoters; under oxidative stress Nrf2 escapes Keap1-mediated repression and upregulates GSH synthesis [4]. Degradation and inter-organ turnover proceed via the γ-glutamyl cycle: exported GSH is broken down by GGT and dipeptidases into amino acids that re-enter the cell, closing the sulfur- and amino-acid-transport loop [1][11].
Molecular mechanism
The biochemical roles of GSH are manifold. As a direct scavenger it neutralizes the hydroxyl radical and singlet oxygen. As an enzyme cofactor it fuels the glutathione peroxidases (GPx), which reduce H₂O₂ and lipid hydroperoxides to water and alcohols while being oxidized to GSSG; regeneration of GSH from GSSG is carried out by glutathione reductase (GR) at the expense of NADPH, supplied mainly by the pentose phosphate pathway [5][6]. This "glutathione antioxidant axis" (GSH ↔ GSSG, GPx, GR, NADPH) is one of the cell's two major thiol redox systems alongside the thioredoxin system.
A separate large class is the glutathione S-transferases (GST), which conjugate GSH to the electrophilic centers of xenobiotics, carcinogens, and endogenous lipid-peroxidation products (e.g., 4-hydroxynonenal), initiating the mercapturic-acid detoxification pathway; some GST isoforms also have non-catalytic regulatory roles by binding kinases [7]. GSH also participates in the regeneration of ascorbate and α-tocopherol, in nitric-oxide metabolism (S-nitrosoglutathione, GSNO), and in the degradation of methylglyoxal by the glyoxalase system [11].
Signaling and downstream effects
Beyond its antioxidant function, GSH participates in redox signaling through reversible S-glutathionylation, the attachment of glutathione to protein cysteine residues. This post-translational modification alters the activity of numerous targets (e.g., actin, Ras, PTP1B, ion channels, transcription factors) and protects critical thiols from irreversible over-oxidation; the mark is removed by glutaredoxins (Grx) [8]. Through control of redox potential and glutathionylation, GSH influences proliferation, differentiation, and apoptosis: GSH depletion and an oxidizing shift in GSH/GSSG both precede and accompany caspase activation, while GSH efflux is an early step in some apoptotic programs [8]. The thiol redox state is thus both a "shield" and a regulatory signal.
Preclinical research findings
Model systems make wide use of pharmacological tools to manipulate the GSH pool. L-Buthionine sulfoximine (BSO), a specific irreversible inhibitor of GCL, depletes cellular GSH and is a standard means of probing the role of thiols in oxidative stress, tumor sensitivity, and neurotoxicity [3]. Conversely, cell-permeant precursors (N-acetylcysteine, GSH ethyl ester) raise intracellular GSH in culture. Gclm- or Gclc-knockout models show that complete loss of GSH synthesis is embryonically lethal, whereas partial reduction increases tissue vulnerability to oxidants [4]. In numerous animal and cellular models GSH dysregulation accompanies neurodegeneration, hepatotoxicity (the classic model being GSH depletion in acetaminophen overdose), ischemia-reperfusion, and carcinogenesis [9][10].
Clinical and human research (as literature)
The literature describes altered GSH status across many human conditions: decreased GSH and an oxidizing GSH/GSSG shift are documented in neurodegenerative diseases (Parkinson's, Alzheimer's), diabetes, cardiovascular and liver disease, HIV infection, and aging, while increased GST activity is associated with tumor resistance to chemotherapy [9][10]. These observations have made the enzymes of GSH synthesis and conjugation targets of investigational interventions, and the GSH/GSSG ratio itself a biomarker of systemic oxidative stress [10][12]. This is presented solely as a description of the published research record and is not use guidance.
Pharmacokinetics and metabolism
GSH is synthesized and functions predominantly intracellularly; the liver is the principal "exporter" of GSH into plasma and bile. Plasma GSH concentrations are low (micromolar) and turnover is extremely rapid: the half-life of extracellular GSH is measured in minutes owing to cleavage by membrane-bound GGT [1][11]. The intact molecule crosses the plasma membrane poorly, so cells preferentially take up its degradation products (cysteine, cystine, γ-glutamyl amino acids) and resynthesize GSH de novo. Intracellular GSH is compartmentalized: a distinct pool with its own redox potential is maintained in mitochondria (imported by dedicated carriers) and in the endoplasmic reticulum, where a more oxidizing environment favors protein disulfide-bond formation [6][11].
Related compounds and analogues
Closely related reagents include the oxidized form glutathione disulfide (GSSG), S-substituted derivatives (S-nitrosoglutathione GSNO, S-hexylglutathione, glutathione-S-conjugates as GST substrates/inhibitors), cell-permeant esters (GSH mono/diethyl ester), and cysteine precursors: N-acetyl-L-cysteine (NAC) and 2-oxothiazolidine-4-carboxylate. Functional analogues by redox role include the thioredoxin system, as well as the microbial thiols mycothiol (in actinobacteria) and bacillithiol, which serve GSH-like roles in prokaryotes. The synthetic GCL inhibitor BSO is a key pharmacological antagonist analogue for research modulation of the pool [3][7].
Analytical characterization
Quantitation and purity control employ reversed-phase HPLC (high-performance liquid chromatography) with UV detection (215 nm) or with pre-column thiol derivatization (Ellman's reagent DTNB, monobromobimane, o-phthalaldehyde) for fluorimetry. Separation of GSH/GSSG and identity confirmation are performed by LC-MS/MS (deprotonated [M-H]⁻ ion m/z 306 for GSH, m/z 611 for GSSG) [5][12]. The Tietze enzymatic recycling assay (GR/DTNB/NADPH) remains the reference method for total glutathione. Identity is further confirmed by ¹H/¹³C NMR and IR spectroscopy; raw material is checked for optical activity (specific rotation), heavy-metal content, and residual moisture. A key analytical caveat is artefactual oxidation of GSH to GSSG during sample preparation, so samples are stabilized with acid and chelators.
Handling, reconstitution chemistry and storage
GSH is hygroscopic and sensitive to air oxidation. Fresh aqueous solutions are prepared in deionized water or a mildly acidic buffer immediately before use; adding a chelator (EDTA) slows metal-catalyzed autoxidation, and degassing/an inert-gas atmosphere minimizes GSSG formation. Solutions at neutral and alkaline pH oxidize quickly and are therefore not stored for long. The dry powder is kept sealed, protected from moisture and light at low temperature; working aliquots are frozen, avoiding repeated freeze-thaw cycles. All handling is conducted under laboratory conditions consistent with the reagent's RUO status.
Research applications and model systems
In research practice GSH serves as a standard for calibrating analytical thiol assays; as a substrate/cofactor in kinetic studies of GPx, GR, GST, and glyoxalases; as a buffer component to maintain a reducing environment and correct folding of free-thiol proteins; for studies of S-glutathionylation and redox signaling; and in cellular and animal models of oxidative stress, xenobiotic detoxification, and mitochondrial bioenergetics [5][6][11]. The GSH/GSSG couple functions as a reference redox indicator, and modulation of the pool (BSO versus precursors) is a standard tool for causal analysis of the role of thiols [3][12]. This portfolio of uses has established glutathione as one of the most extensively studied small molecules in redox biology.